Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity

A shortage of blood during the pandemic outbreak of COVID-19 is a typical example in which the maintenance of a safe and adequate blood supply becomes difficult and highly demanding. So far, human RBCs have been produced in vitro using diverse sources: hematopoietic stem cells (SCs), embryonic SCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanza, Francesco, Seghatchian, Jerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474814/
https://www.ncbi.nlm.nih.gov/pubmed/32958397
http://dx.doi.org/10.1016/j.transci.2020.102941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474814/
https://www.ncbi.nlm.nih.gov/pubmed/32958397
http://dx.doi.org/10.1016/j.transci.2020.102941

Ejemplares similares